Presentations from IPAC-RS / ISAM Congress Workshop now available for download!

Following the ISAM 2023 Congress, we have new content and provide ISAM members with exclusive access to the IPAC-RS / ISAM workshop held in Saarbrücken 2023 covering the presentations on inhaled/nasal delivery of biologics.

Chairs of the workshop:

• David Cipolla, Insmed Incorporated, United States of America
• Lana Lyapustina, IPAC-RS Secretariat, United States of America
• Franz-Josef Rehmann, AstraZeneca, Sweden

The following presentations are now available for download following this link (members only): 
Link to IPAC-RS / ISAM workshop presentations

• David Cipolla, Insmed Incorporated, USA: The first approved inhaled protein: Pulmozyme rhDNase
• Philip Kuehl, LOVELACE Biomedical, United States of America: Measuring/Controlling the impact of aerolisation on the structure and activity of inhaled biologics
• Chris Gruenloh, PPD, United States of America: DDU and APSD testing: Alternatives for aerolisation and detection of biologics
• Nani Kadrichu, Consultant, United States of America: Phase-appropriate testing for development of inhaled biologics
• Lei Mao, Recipharm, United States of America: Nasal Biologics – formulation and analytical considerations
• Carina Simons, BfArM, Germany: Defining the regulatory landscape for inhaled biologics: work in progress
• Bing Li, FDA, United States of America: Scientific and regulatory considerations on establishing bioequivalence for generic inhaled biologics

The membership area offers further publications, direct journal access, registered member listing, and educational materials. Our membership platform provides many presentations from webinars, symposia and our congresses and we offer access to file libraries that are offered via our Networking Groups. Many webinars are also available online on demand. You can find the link below or access to the videos in the news section of our website.